Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: Sympathetic Ablation for Ventricular Arrhythmias [NA]

View source ↗

Summary

A SymKardia-led trial update describes sympathetic ablation being studied for ventricular tachycardia, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: SymKardia | Conditions: Ventricular Tachycardia (VT) | NA | Status: NOT_YET_RECRUITING